Dendreon's Phase I Results of APC8024 -- anti-HER-2 Therapeutic Vaccine Demonstrate Ongoing Clinical Benefit in Women with Advanced Metastatic Breast Cancer as reported at the American Society of Clinical Oncology 2003 Annual Meeting

Thank you for your prompt article submissiom. I just sent an e-mail to Linda Marker and Dr. Park I thought it was a good idea to introduce our site to these scienyists who may need a future vehicle to work with to link on to our site if the future success of the research permits.